Clinical News

Clinical Status

<div class="articleContainer"><div class="articleWrapper"><div class="articleContent"><h1 class="text title">Evista raloxifene: Completed Phase III trial enrollment</h1><div class="byline">WIR Staff</div><div class="date"></div></div></div></div>

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

Evista is marketed to prevent and treat osteoporosis in postmenopausal women. ......

cancer

Cardiovascular

Endocrine / Metabolic

Musculoskeletal

Neurology

Evista raloxifene: Completed Phase III trial enrollment

Featured Analysis

Articles by Category

Current Editions

Data Graphics

Distillery: Disruptive Innovation

Distillery

Hot Topics

Podcasts & Webcasts

Special Reports & Presentations

White Papers

Analysis

BCIQ

Company Profiles

Product Profiles

Target Profiles

Financial Dashboards

BCIQ Data

All Events

BioCentury Grand Rounds 2024

BioCentury Grand Rounds

The BioCentury-BayHelix China Healthcare Summit

BioCentury-BayHelix China Healthcare Summit

BioCentury-BIA Jefferies 2024

The BioCentury-BayHelix East-West BioPharma Summit

BioCentury-BayHelix East-West Summit

Bio€quity Europe

The BioCentury Show

Webinars - Upcoming & On-Demand

Events

My Workspace

Management

Analysts & Research Team

Scientific Advisory Board

About BioCentury

Contact Us

Forgot Password

Request a Trial

Request a Subscription

Sponsorship & Branding Inquiry 

Media Kit

Request BioCentury's BCIQ Brochure

Customer Resource Center

Career Opportunities

Contact

Home